![Esper Boel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Esper Boel
Direktor/Vorstandsmitglied bei
MonTa Biosciences ApS
Profil
Esper Boel is currently a Director at MonTa Biosciences ApS.
Prior to this, he held positions as Head-Biotechnology Unit at Novo Nordisk A and Senior Vice President & Head-Discovery at Symphogen A. Boel received his undergraduate and doctorate degrees from the University of Aarhus in 1979.
Aktive Positionen von Esper Boel
| Unternehmen | Position | Beginn |
|---|---|---|
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Esper Boel
| Unternehmen | Position | Ende |
|---|---|---|
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Technik-/Wissenschafts-/F&E-Leiter | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ausbildung von Esper Boel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
